Over the past thirty years, the world's patent systems have experienced pressure from civil society like never before. From farmers to patient advocates, new voices are arguing that patents impact public health, economic inequality, morality--and democracy. These challenges, to domains that we usually consider technical and legal, may seem surprising. But in Patent Politics, Shobita Parthasarathy argues that patent systems have always been deeply political and social.
To demonstrate this, Parthasarathy takes readers through a particularly fierce and prolonged set of controversies over patents on life forms linked to important advances in biology and agriculture and potentially life-saving medicines. Comparing battles over patents on animals, human embryonic stem cells, human genes, and plants in the United States and Europe, she shows how political culture, ideology, and history shape patent system politics. Clashes over whose voices and which values matter in the patent system, as well as what counts as knowledge and whose expertise is important, look quite different in these two places. And through these debates, the United States and Europe are developing very different approaches to patent and innovation governance. Not just the first comprehensive look at the controversies swirling around biotechnology patents, Patent Politics is also the first in-depth analysis of the political underpinnings and implications of modern patent systems, and provides a timely analysis of how we can reform these systems around the world to maximize the public interest.
Upcoming Book Talks and Interviews
School of Public Policy, Georgia Tech, Atlanta, GA, October 2017.
Talking Biopolitics webcast, Center for Genetics and Society, November 2017.
Recent Book Talks (and videos)
Keynote Speaker, Intellectual Property, Ethics, and the Market Conference, Centre for Personalised Medicine, Wellcome Trust Centre for Human Genomics, University of Oxford, UK, June 12-13, 2017.
Book Launch event at Patents, Social Justice, and Public Responsibility Symposium, Sponsored by the Institute for the Humanities and Ford School of Public Policy, University of Michigan, March 27, 2017 (View the video here.)
Keynote Speaker, Fifth Annual Conference on Governance of Emerging Technologies: Law, Policy and Ethics, Arizona State University, May 17-19, 2017.
"Patent Politics" Tech Talk, Center for Democracy and Technology, March 30, 2017.
Bruce G. Carruthers, Northwestern University
“Patent offices play a crucial role in the development of innovative global industries like biotech, pharmaceuticals, and IT. Parthasarathy’s comparative analysis explores the puzzling and durable differences between the US and European patent systems. Meticulously researched and clearly written, this important book provides an insightful analysis that opens new questions about the limits of globalization and the continuing importance of political forces in shaping intellectual property.”
Daniel Kleinman, University of Wisconsin, Madison
“Patent Politics is well crafted, with sharp comparison, strong analysis, and sound data. Parthasarathy offers a timely study that spans several fields: science and technology studies, science and technology policy, comparative politics, and political sociology. Patent Politics will be widely read and cited by anyone with an interest in the past, present, or future of patents in the United States and Europe.”
Eva Hemmungs Wirtén, Linköping University
“Parthasarathy's comparative approach to looking at the United States and Europe is intriguing and makes a significant contribution to the current state of the art—showing how differences in legal, cultural, and political traditions pertain to policies in respect to the life sciences. She not only provides a detailed account of the controversies surrounding life form patenting, but also vividly shows how the troubled legal regime of intellectual property results from negotiation with a whole set of actors, networks, and texts that are seen as external to the law. Patent Politics is an important, timely, and impressive contribution to the field.”
"As critical policy scholars have a longstanding interest in controversies stemming from scientific and medical innovations, this book will be of great interest thematically and adds to the growing dialog between science studies and policy studies." --Critical Policy Studies
Related Scholarly and Opinion Articles
Shobita Parthasarathy. “Patents and Politics.” In Sahra Gibbon, Barbara Prainsack, Stephen Hilgartner, and Janelle Lamoureaux, eds., Handbook of Genomics, Health and Society. Routledge, forthcoming.
Shobita Parthasarathy (July 19, 2017). “How to make sure we all benefit when nonprofits patent technologies like CRISPR.” The Conversation.
Shobita Parthasarathy (2016). “Governance Lessons for CRISPR from the Missed Opportunities of Asilomar.” Ethics in Biology, Engineering, and Medicine. Vol. 6, No. 3-4, p. 305-312.
Shobita Parthasarathy (April 4, 2016). "CRISPR Dispute Raises Bigger Patent Issues That We're Not Talking About." The Conversation. (reprinted in Singularity Hub, Phys.org among other outlets)
Shobita Parthasarathy (July 31, 2015). “An early expression of democracy, the US patent system is out of step with today’s citizens.” The Conversation. (reprinted in Science Codex among other outlets)
Shobita Parthasarathy (2015). “Co-Producing Knowledge and Political Legitimacy: Comparing the Life Form Patent Controversies in Europe and the United States.” In Stephen Hilgartner, Clark Miller, and Rob Hagendijk, eds., Science and Democracy: Emerging Trends. Routledge.
Shobita Parthasarathy (2014). “Observing the Patent System in Social and Political Perspective: A Case Study of Europe.” (with Alexis Walker) In Margo Bagley and Ruth Okediji, eds., Global Perspectives on Patent Law, New York: Oxford University Press.
Shobita Parthasarathy (2011). “Whose Knowledge? Whose Values? The Comparative Politics of Patenting Life Forms in the United States and Europe.” Policy Sciences. Vol 44, No. 3, p. 267-288.
Shobita Parthasarathy (2010). “Breaking the Expertise Barrier: Understanding Activist Challenges to Science and Technology Policy Domains.” Science & Public Policy. Vol. 37, No. 5, pp. 355-367).